In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
The decision on the India-US trade agreement now rests with the US, as the Indian government has
Jagat Singh, BJP district head of Bharatpur in Rajasthan, has given a controversial statement reg
AIMIM chief Asaduddin Owaisi criticized the proposed Waqf Amendment Bill of the Central Governmen
Facebook's new name is Meta. Meta means metaverse. Metaverse means virtual reality. Simply put, a
Corona has once again knocked in China. More than 80 thousand tourists are stuck in the resort ci
The Supreme Court on Thursday remarked that the acute shortage of drinking water in Delhi has bec
The Waqf Amendment Bill has been challenged in the Supreme Court. However, it has been signed by
ICC has released the batsmen's ranking of T20 International. In this ranking, India's star batsma
Chinese sleeper cells were being prepared thereby operating a pub named Tiangshang Rangian in a b
Mumbai: There are indications of malls opening again, guidelines may be issued by this evening
With the decline in corona cases, lockdown restrictions are being relaxed in many states. In this
